Pan, Chin

AbbVie (United States)

1 paper on CoChatORCID 0009-0008-2832-8303

Most cited papers

Verified
Abbv-101, a Highly Potent and Selective Clinical Stage Bruton Tyrosine Kinase Degrader for the Treatment of B-Cell Malignancies
Pan, C., Gururaja, T. L., Li, H., Nguyen, H., Zhai, Y., Xie, X., Ding, R.-X., Mathew, R., Hoh, H. Y., Jia, Z. J., et al. (2023) · Blood
Protein Degradation and InhibitorsChronic Lymphocytic Leukemia Research
Cited by 10

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free